New variant Creutzfeldt-Jakob disease and white cell reduction: Risk assessment and decision making in the absence of data

Transfusion

Volumn 39, Issue 9, 1999, Pages 920-924

  Kleinman, S ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD TRANSFUSION; CREUTZFELDT JAKOB DISEASE; DECISION MAKING; EDITORIAL; HUMAN; LEUKOCYTE COUNT; LEUKOPENIA; RISK ASSESSMENT; UNITED KINGDOM; VIRUS INFECTIVITY; VIRUS TRANSMISSION;

EID: 0032845054     PISSN: 00411132     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1537-2995.1999.39090920.x     Document Type: Editorial

References (15)

1. 1 Will RG, Ironside JW, Zeidler M, et al. A new variant of Creutzfeldt‐Jakob disease in the UK. Lancet 1996 ; 347: 921–5.
2. 2 Will RG. Creutzfeldt‐Jacob disease and the blood supply. Presented at the Canadian National Blood Safety Council Forum, Vancouver, BC, Canada, May 1999.
3. 3 Murphy MF. New variant Creutzfeldt‐Jakob disease (nvCJD): the risk of transmission by blood transfusion and the potential benefit of leukocyte‐reduction of blood components. Transfus Med Rev 1999 ; 13: 75–83.
4. 4 Assessment of the risk of exposure to vCJD infectivity in blood and blood products. Final report for the Spongiform Encephalopathy Advisory Committee and the Department of Health, United Kingdom. London: Det Norske Veritas, 1999.
5. 5 Brown P. Can Creutzfeldt‐Jakob disease be transmitted by transfusion? Curr Opin Haematol 1995 ; 2: 472–7.
6. 6 Hill AF, Debruslais M, Joiner S, et al. The same prion strain causes vCJD and BSE (letter). Nature 1997 ; 389: 448–50, 526.
7. 7 Hill AF, Butterworth RJ, Joiner S, et al. Investigation of variant Creutzfeldt‐Jakob disease and other human prion diseases with tonsil biopsy samples. Lancet 1999 ; 353: 183–9.
8. 8 Brown P, Rowher RG, Dunston BC, et al. The distribution of infectivity in blood components and plasma derivatives in experimental models of transmissible spongiform encephalopathy. Transfusion 1998 ; 38: 810–6.
9. 9 Klein MA, Frigg R, Flechsig E, et al. A crucial role for B cells in neuroinvasive scrapie. Nature 1997 ; 390: 687–90.
10. 10 Brown P. B lymphocytes and neuroinvasion (news; comment). Nature 1997 ; 390: 662–3.
11. 11 Krever H. Commission of Inquiry on the Blood System in Canada. Final report. Ottawa: Canadian Government Publishing, 1997.
12. 12 Hoey J, Giulivi A, Todkill AM. New variant Creutzfeldt‐Jakob disease and the blood supply: is it time to face the music? (editorial). CMAJ 1998 ; 159: 669–70.
13. 13 Busch MP. To thy (reactive) donors be true! (editorial). Transfusion 1997 ; 37: 117–20.
14. 14 Dodd RY, Sullivan MT. Creutzfeldt‐Jakob disease and transfusion safety: tilting at icebergs? (editorial). Transfusion 1998 ; 38: 221–3.
15. 15 AuBuchon JP, Birkmeyer JD, Busch MP. Cost‐effectiveness of expanded human immunodeficiency virus‐testing protocols for donated blood. Transfusion 1997 ; 37: 45–51.